Skip to main content
. 2014 Jul 2;31(7):762–775. doi: 10.1007/s12325-014-0132-x

Table 2.

Incidence of adverse events

Variable Patients (n = 11,321)
Any AE, n (%) 164 (1.4)
Any SAE, n (%) 3 (<0.1)
AE related to treatment, n (%) 64 (0.6)
SAE related to treatment, n (%) 0 (0.0)
Discontinuations due to AEs, n (%) 22 (0.2)
Most frequent AEs, n (%)
 Dizziness 27 (0.2)
 Headache 25 (0.2)
 Edema 19 (0.2)
 Upper respiratory tract infection 18 (0.2)
 Cough 9 (0.1)

AE adverse event, SAE serious adverse event